Novel neural pathways targeted by GLP-1R agonists and bariatric surgery
Pflügers Archiv - European Journal of Physiology · 2025-02 · 477 (2) · 171-185
DOI: 10.1007/s00424-024-03047-3 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pflügers Archiv - European Journal of Physiology, online erschienen am 07.12.2024. Verfasst von Mohammed K Hankir und 1 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Veterinary Physiology, University of Zurich, Zurich, Switzerland. Hauptthemen laut MEDLINE: Bariatric Surgery, Glucagon-Like Peptide-1 Receptor Agonists, Obesity, Neural Pathways. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 175 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung, University of Zurich.
Abstract (Originalsprache)
The glucagon-like peptide 1 receptor (GLP-1R) agonist semaglutide has revolutionized the treatment of obesity, with other gut hormone-based drugs lined up that show even greater weight-lowering ability in obese patients. Nevertheless, bariatric surgery remains the mainstay treatment for severe obesity and achieves unparalleled weight loss that generally stands the test of time. While their underlying mechanisms of action remain incompletely understood, it is clear that the common denominator between GLP-1R agonists and bariatric surgery is that they suppress food intake by targeting the brain. In this Review, we highlight recent preclinical studies using contemporary neuroscientific techniques that provide novel concepts in the neural control of food intake and body weight with reference to endogenous GLP-1, GLP-1R agonists, and bariatric surgery. We start in the periphery with vagal, intestinofugal, and spinal sensory nerves and then progress through the brainstem up to the hypothalamus and finish at non-canonical brain feeding centers such as the zona incerta and lateral septum. Further defining the commonalities and differences between GLP-1R agonists and bariatric surgery in terms of how they target the brain may not only help bridge the gap between pharmacological and surgical interventions for weight loss but also provide a neural basis for their combined use when each individually fails.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Veterinary Physiology, University of Zurich, Zurich, Switzerland.
- School of Biochemistry and Immunology, Trinity College Dublin, Dublin, Ireland.
- Institute of Veterinary Physiology, University of Zurich, Zurich, Switzerland. thomas.lutz@uzh.ch.
Förderung
- Deutsche Forschungsgemeinschaft
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
- University of Zurich
Zitieren
APA
Hankir, M. K., & Lutz, T. A. (2025). Novel neural pathways targeted by GLP-1R agonists and bariatric surgery. Pflügers Archiv - European Journal of Physiology, 477(2), 171-185. https://doi.org/10.1007/s00424-024-03047-3
Vancouver
Hankir MK, Lutz TA. Novel neural pathways targeted by GLP-1R agonists and bariatric surgery. Pflügers Archiv - European Journal of Physiology. 2025;477(2):171-185. doi:10.1007/s00424-024-03047-3
BibTeX
@article{Hankir2025,
author = {Hankir, Mohammed K and Lutz, Thomas A},
title = {Novel neural pathways targeted by GLP-1R agonists and bariatric surgery},
journal = {Pflügers Archiv - European Journal of Physiology},
year = {2025},
volume = {477},
number = {2},
pages = {171--185},
doi = {10.1007/s00424-024-03047-3}
}
EUVIMED